Cargando…

Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants

Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G (ARSG) gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Velde, Hedwig M., Reurink, Janine, Held, Sebastian, Li, Catherina H. Z., Yzer, Suzanne, Oostrik, Jaap, Weeda, Jack, Haer-Wigman, Lonneke, Yntema, Helger G., Roosing, Susanne, Pauleikhoff, Laurenz, Lange, Clemens, Whelan, Laura, Dockery, Adrian, Zhu, Julia, Keegan, David J., Farrar, G. Jane, Kremer, Hannie, Lanting, Cornelis P., Damme, Markus, Pennings, Ronald J. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556359/
https://www.ncbi.nlm.nih.gov/pubmed/35226187
http://dx.doi.org/10.1007/s00439-022-02441-0
_version_ 1784807060579287040
author Velde, Hedwig M.
Reurink, Janine
Held, Sebastian
Li, Catherina H. Z.
Yzer, Suzanne
Oostrik, Jaap
Weeda, Jack
Haer-Wigman, Lonneke
Yntema, Helger G.
Roosing, Susanne
Pauleikhoff, Laurenz
Lange, Clemens
Whelan, Laura
Dockery, Adrian
Zhu, Julia
Keegan, David J.
Farrar, G. Jane
Kremer, Hannie
Lanting, Cornelis P.
Damme, Markus
Pennings, Ronald J. E.
author_facet Velde, Hedwig M.
Reurink, Janine
Held, Sebastian
Li, Catherina H. Z.
Yzer, Suzanne
Oostrik, Jaap
Weeda, Jack
Haer-Wigman, Lonneke
Yntema, Helger G.
Roosing, Susanne
Pauleikhoff, Laurenz
Lange, Clemens
Whelan, Laura
Dockery, Adrian
Zhu, Julia
Keegan, David J.
Farrar, G. Jane
Kremer, Hannie
Lanting, Cornelis P.
Damme, Markus
Pennings, Ronald J. E.
author_sort Velde, Hedwig M.
collection PubMed
description Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G (ARSG) gene have been reported to underlie USH type IV. This distinct type of USH is characterized by late-onset RP with predominantly pericentral and macular changes, and late onset SNHL without vestibular dysfunction. In this study, we describe the USH type IV phenotype in three unrelated subjects. We identified three novel pathogenic variants, two novel likely pathogenic variants, and one previously described pathogenic variant in ARSG. Functional experiments indicated a loss of sulfatase activity of the mutant proteins. Our findings confirm that ARSG variants cause the newly defined USH type IV and support the proposed extension of the phenotypic USH classification. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00439-022-02441-0.
format Online
Article
Text
id pubmed-9556359
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95563592022-10-14 Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants Velde, Hedwig M. Reurink, Janine Held, Sebastian Li, Catherina H. Z. Yzer, Suzanne Oostrik, Jaap Weeda, Jack Haer-Wigman, Lonneke Yntema, Helger G. Roosing, Susanne Pauleikhoff, Laurenz Lange, Clemens Whelan, Laura Dockery, Adrian Zhu, Julia Keegan, David J. Farrar, G. Jane Kremer, Hannie Lanting, Cornelis P. Damme, Markus Pennings, Ronald J. E. Hum Genet Original Investigation Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G (ARSG) gene have been reported to underlie USH type IV. This distinct type of USH is characterized by late-onset RP with predominantly pericentral and macular changes, and late onset SNHL without vestibular dysfunction. In this study, we describe the USH type IV phenotype in three unrelated subjects. We identified three novel pathogenic variants, two novel likely pathogenic variants, and one previously described pathogenic variant in ARSG. Functional experiments indicated a loss of sulfatase activity of the mutant proteins. Our findings confirm that ARSG variants cause the newly defined USH type IV and support the proposed extension of the phenotypic USH classification. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00439-022-02441-0. Springer Berlin Heidelberg 2022-02-28 2022 /pmc/articles/PMC9556359/ /pubmed/35226187 http://dx.doi.org/10.1007/s00439-022-02441-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Investigation
Velde, Hedwig M.
Reurink, Janine
Held, Sebastian
Li, Catherina H. Z.
Yzer, Suzanne
Oostrik, Jaap
Weeda, Jack
Haer-Wigman, Lonneke
Yntema, Helger G.
Roosing, Susanne
Pauleikhoff, Laurenz
Lange, Clemens
Whelan, Laura
Dockery, Adrian
Zhu, Julia
Keegan, David J.
Farrar, G. Jane
Kremer, Hannie
Lanting, Cornelis P.
Damme, Markus
Pennings, Ronald J. E.
Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants
title Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants
title_full Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants
title_fullStr Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants
title_full_unstemmed Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants
title_short Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants
title_sort usher syndrome type iv: clinically and molecularly confirmed by novel arsg variants
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556359/
https://www.ncbi.nlm.nih.gov/pubmed/35226187
http://dx.doi.org/10.1007/s00439-022-02441-0
work_keys_str_mv AT veldehedwigm ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT reurinkjanine ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT heldsebastian ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT licatherinahz ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT yzersuzanne ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT oostrikjaap ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT weedajack ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT haerwigmanlonneke ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT yntemahelgerg ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT roosingsusanne ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT pauleikhofflaurenz ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT langeclemens ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT whelanlaura ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT dockeryadrian ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT zhujulia ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT keegandavidj ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT farrargjane ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT kremerhannie ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT lantingcornelisp ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT dammemarkus ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants
AT penningsronaldje ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants